The FDA has approved subcutaneous daratumumab and hyaluronidase-fihj (Darzalex Faspro) for use in patients with high-risk ...

If you’re exploring fertility treatments, you might have come across Lupride injections. Knowing about what Lupride is, how ...

The global injection pen market is expected to grow at a rate of 7% over the next five years. Key factors fueling this growth include the rising prevalence of chronic diseases, the increasing demand ...

At AHA 2025, data from the SCORE-HF study (NCT07141914) were presented, evaluating Novo Nordisk’s semaglutide 2.4mg and its ...

This article was reviewed by Darragh O’Carroll, MD. Oral vs. Injectable Semaglutide: Effectiveness & Side Effects Key ...

Zalunfiban, a prehospital platelet inhibitor given by injection at the point of first medical contact for suspected STEMI, ...

Sometime within the last fortnight, several engagements with readers convinced yours truly that some degree of education was necessary about the dangers individuals face when taking various types of ...

New Zealanders living with multiple sclerosis, breast cancer, eye conditions, and lung cancer will benefit from five medicines that Pharmac will fund from 1 December 2025.

“Today’s decisions show the culture we are building at Pharmac. Pharmac listened to what patients want. They funded medicines to make patients’ lives easier, and reduce strain on the health system,” ...

A group of patients with advanced breast cancer will be the first to be able to receive a taxpayer-funded medicine in private ...

SE (EURONEXT: ARGX) (Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today announced that Health Canada has issued a ...

Associate Health Minister with responsibility for Pharmac David Seymour, and Health Minister Simeon Brown welcome Pharmac's decision to fund access to ...